Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease.
Joan DuprezJean-François HouvenaghelSophie DrapierManon AuffretDominique DrapierGabriel RobertMarc VérinPaul SauleauPublished in: Journal of neurology (2017)
We found no difference between M0 and M6, which strongly suggests that CSAI does not impair the dynamics of cognitive action control.
Keyphrases